TLIS Alert: Johnson Fistel Launches Investigation into Talis Biomedical - Stock Price has Plummeted since IPO; Investors Suffering Losses Encouraged to Contact the Firm
Talis Biomedical Corporation - common stock (TLIS)
Company Research
Source: GlobeNewswire
SAN DIEGO, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). On or about February 12, 2021, Talis sold approximately 13.8 million shares of stock in its initial public stock offering (the "IPO") at $16 a share, raising nearly $221 million in new capital. Since the IPO, the stock has plummeted, closing at $8.44 on September 2, 2021. On August 10, 2021, Talis reported its 2nd quarter financial results. During the earnings call, it was disclosed that “In the near term, our development time lines have been extended by delays in the launching of our COVID-19 test and manufacturing scale.” Then, on August 30, 2021, Talis announced that its President, CEO, and Director resigned. Specifically, Johnson Fistel's investigation seeks to determine whether the Company's filings with the U.S. Securities and Exchange Com
Show less
Read more
Impact Snapshot
Event Time:
TLIS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLIS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLIS alerts
High impacting Talis Biomedical Corporation - common stock news events
Weekly update
A roundup of the hottest topics
TLIS
News
- Respiratory Infection Diagnostic Technology Market Analysis Report 2024: Multiplex Advancements and Geographic Expansion 2023-2027 - Diagnostic Sector Witnesses Surge [Yahoo! Finance]Yahoo! Finance
- TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
TLIS
Sec Filings
- 4/11/24 - Form 8-K
- 4/1/24 - Form EFFECT
- 3/28/24 - Form 10-K
- TLIS's page on the SEC website